Schedule 13G ownership disclosure

F-STAR THERAPEUTICS INC

Security class unavailable · CUSIP: 30315R107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
75,140
Percent of class
0.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-22-000273
Form type
SC 13G/A
Filer
F-star Therapeutics, Inc.
CIK
CIK 1566373
Filed
Feb 08, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub